Literature DB >> 20944094

Transient metals enhance cytotoxicity of curcumin: potential involvement of the NF-kappaB and mTOR signaling pathways.

Jessica R Lou1, Xiao-Xi Zhang, Jie Zheng, Wei-Qun Ding.   

Abstract

BACKGROUND/AIM: Curcumin has been recognized as a metal-binding compound and an anticancer agent, yet the involvement of metals in the anticancer action of curcumin remains unclear. The present study examined the role of transient metals in curcumin-induced cytotoxicity in cancer cells.
MATERIALS AND METHODS: Metal-binding activity and cytotoxicity of curcumin were examined in human cancer lines with cell viability assay, confocal microscopy, Western blot, and measurement of hydrogen peroxide generation.
RESULTS: It was found that Cu (II) most significantly potentiated the cytotoxicity of curcumin among the metals tested. The combination of curcumin and Cu (II) did not generate reactive oxygen species and vitamin E did not block the cytotoxicity. Curcumin plus Cu (II) enhanced intracellular copper levels and potentiated curcumin-induced suppression of the nuclear factor kappa B (NF-κB) pathway, as well as alterations of mammalian target of rapamycin-raptor (mTOR) signaling.
CONCLUSION: Transient metals enhance the cytotoxicity of curcumin, likely through targeting of the NF-κB and mTOR signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944094

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  The short-time treatment with curcumin sufficiently decreases cell viability, induces apoptosis and copper enhances these effects in multidrug-resistant K562/A02 cells.

Authors:  Jin-Jian Lu; Yu-Jun Cai; Jian Ding
Journal:  Mol Cell Biochem       Date:  2011-09-22       Impact factor: 3.396

2.  Copper complexation screen reveals compounds with potent antibiotic properties against methicillin-resistant Staphylococcus aureus.

Authors:  Mehri Haeili; Casey Moore; Christopher J C Davis; James B Cochran; Santosh Shah; Tej B Shrestha; Yaofang Zhang; Stefan H Bossmann; William H Benjamin; Olaf Kutsch; Frank Wolschendorf
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

3.  Trolox enhances curcumin's cytotoxicity through induction of oxidative stress.

Authors:  Jie Zheng; Kelsey Payne; Jori E Taggart; Hongchao Jiang; Stuart E Lind; Wei-Qun Ding
Journal:  Cell Physiol Biochem       Date:  2012-04-03

4.  Inhibitory Effect of Curcumin-Cu(II) and Curcumin-Zn(II) Complexes on Amyloid-Beta Peptide Fibrillation.

Authors:  Rona Banerjee
Journal:  Bioinorg Chem Appl       Date:  2014-07-23       Impact factor: 7.778

5.  Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status.

Authors:  Kunio Yui; George Imataka; Hitomi Sasaki; Yohei Kawasaki; Tohru Okanshi; Ryoichi Shiroki; Shigemi Yoshihara
Journal:  Case Rep Pediatr       Date:  2019-11-23

6.  Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy.

Authors:  Kavita Gaur; Alexandra M Vázquez-Salgado; Geraldo Duran-Camacho; Irivette Dominguez-Martinez; Josué A Benjamín-Rivera; Lauren Fernández-Vega; Lesly Carmona Sarabia; Angelys Cruz García; Felipe Pérez-Deliz; José A Méndez Román; Melissa Vega-Cartagena; Sergio A Loza-Rosas; Xaymara Rodriguez Acevedo; Arthur D Tinoco
Journal:  Inorganics (Basel)       Date:  2018-11-30

7.  CTR1 silencing inhibits angiogenesis by limiting copper entry into endothelial cells.

Authors:  Gomathy Narayanan; Bharathidevi S R; Harish Vuyyuru; Bharathselvi Muthuvel; Sulochana Konerirajapuram Natrajan
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

8.  Up-regulation of CacyBP/SIP during rat breast cancer development.

Authors:  Ewa Kilańczyk; Krzysztof Gwoździński; Ewa Wilczek; Anna Filipek
Journal:  Breast Cancer       Date:  2012-08-28       Impact factor: 4.239

9.  Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives.

Authors:  Shireen Parsai; Rick Keck; Ewa Skrzypczak-Jankun; Jerzy Jankun
Journal:  Oncol Lett       Date:  2013-11-12       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.